Short-term duodenal seal oil administration normalised n-6 to n-3 fatty acid ratio in rectal mucosa and ameliorated bodily pain in patients with inflammatory bowel disease

Lipids in Health and Disease

Volumn 5, Issue , 2006, Pages

  Bjørkkjær, Tormod ^a,b   Brun, Johan G ^c   Valen, Merete ^c   Arslan, Gülen ^a,c   Lind, Ragna ^c   Brunborg, Linn A ^a   Berstad, Arnold ^c   Frøyland, Livar ^a  

^a INSTITUTE OF MARINE RESEARCH   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EDIBLE OIL; FISH OIL; ICOSANOID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; SOYBEAN OIL;

ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DIETARY INTAKE; ENTERITIS; HUMAN; LIPID COMPOSITION; PAIN; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECTUM MUCOSA; SCORING SYSTEM; SEA FOOD; SEAL;

AGED; ANIMALS; ARTHRALGIA; BIOPSY; DIETARY FATS, UNSATURATED; DUODENUM; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FISH OILS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LINOLEIC ACID; MALE; MIDDLE AGED; PILOT PROJECTS; QUALITY OF LIFE; QUESTIONNAIRES; RECTUM; SEALS, EARLESS; SOYBEAN OIL; TIME FACTORS;

EID: 33744456249     PISSN: 1476511X     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-5-6     Document Type: Article

References (35)

1. Burdge GC, Calder PC: Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 2005, 45:581-597.
2. Ruxton CHS, Calder PC, Reed SC, Simpson MJA: The impact of long-chain n-3 polyunsaturated fatty acids on human health. Nutrition Research Reviews 2005, 18:113-129.
3. Calder PC: n-3 fatty acids, inflammation, and immunity - relevance to postsurgical and critically ill patients. Lipids 2004, 39:1147-1161.
4. Gil A: Polyunsaturated fatty acids and inflammatory diseases. Biomed Pharmacother 2002, 56:388-396.
5. Simopoulos AP: Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002, 21:495-505.
6. Simopoulos AP: The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 2002, 56:365-379.
7. Holden W, Orchard T, Wordsworth P: Enteropathic arthritis. Rheum Dis Clin North Am 2003, 29:513-530, viii.
8. Orchard T: Extraintestinal complications of inflammatory bowel disease. Curr Gastroenterol Rep 2003, 5:512-517.
9. Orchard TR, Wordsworth BP, Jewell DP: Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 1998, 42:387-391.
10. Glise H, Wiklund I: Health-related quality of life and gastrointestinal disease. J Gastroenterol Hepatol 2002, 17 Suppl:S72-84.
11. Arslan G, Brunborg LA, Froyland L, Brun JG, Valen M, Berstad A: Effects of duodenal seal oil administration in patients with inflammatory bowel disease. Lipids 2002, 37:935-940.
12. Bjorkkjaer T, Brunborg LA, Arslan G, Lind RA, Brun JG, Valen M, Klementsen B, Berstad A, Froyland L: Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil. Scand J Gastroenterol 2004, 39:1088-1094.
13. Ware Jr. JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483.
14. Loge JH, Kaasa S, Hjermstad MJ, Kvien TK: Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity. J Clin Epidemiol 1998, 51:1069-1076.
15. Ware Jr. JE, Gandek B, Kosinski M, Aaronson NK, Apolone G, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M, Thunedborg K: The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998, 51:1167-1170.
16. Kang JX, Wang J, Wu L, Kang ZB: Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature 2004, 427:504.
17. Palm O, Bernklev T, Moum B, Gran JT: Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life. J Rheumatol 2005, 32:1755-1759.
18. Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR: Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978, 2:117-119.
19. Bang HO, Dyerberg J, Hjoorne N: The composition of food consumed by Greenland Eskimos. Acta Med Scand 1976, 200:69-73.
20. Kromann N, Green A: Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scand 1980, 208:401-406.
21. Brox J, Olaussen K, Osterud B, Elvevoll EO, Bjornstad E, Brattebog G, Iversen H: A long-term seal- and cod-liver-oil supplementation in hypercholesterolemic subjects. Lipids 2001, 36:7-13.
22. Brockerhoff H, Hoyle RJ, Hwang PC, Litchfield C: Positional Distribution of Fatty Acids in Depot Triglycerides of Aquatic Animals. Lipids 1968, 3:24-29.
23. Yoshida H, Kumamaru J, Mawatari M, Ikeda I, Imaizumi K, Tsuji H, Seto A: Lymphatic absorption of seal and fish oils and their effect on lipid metabolism and eicosanoid production in rats. Biosci Biotechnol Biochem 1996, 60:1293-1298.
24. Mu H, Hoy CE: The digestion of dietary triacylglycerols. Prog Lipid Res 2004, 43:105-133.
25. Christensen MS, Hoy CE: Effects of dietary triacylglycerol structure on triacylglycerols of resultant chylomicrons from fish oil- and seal oil-fed rats. Lipids 1996, 31:341-344.
26. Mu H, Porsgaard T: The metabolism of structured triacylglycerols. Prog Lipid Res 2005, 44:430-448.
27. Gibson PR, Muir JG: Reinforcing the mucus: a new therapeutic approach for ulcerative colitis? Gut 2005, 54:900-903.
28. Stremmel W, Merle U, Zahn A, Autschbach F, Hinz U, Ehehalt R: Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis. Gut 2005, 54:966-971.
29. Maclean CH, Mojica WA, Newberry SJ, Pencharz J, Garland RH, Tu W, Hilton LG, Gralnek IM, Rhodes S, Khanna P, Morton SC: Systematic review of the effects of n-3 fatty acids in inflammatory bowel disease. Am J Clin Nutr 2005, 82:611-619.
30. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M: Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996, 334:1557-1560.
31. Luyer MD, Greve JW, Hadfoune M, Jacobs JA, Dejong CH, Buurman WA: Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med 2005, 202:1023-1029.
32. Tracey KJ: Fat meets the cholinergic antiinflammatory pathway. J Exp Med 2005, 202:1017-1021.
33. Tracey KJ: The inflammatory reflex. Nature 2002, 420:853-859.
34. Ulloa L: The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov 2005, 4:673-684.
35. Raybould HE: Nutrient tasting and signaling mechanisms in the gut. I. Sensing of lipid by the intestinal mucosa. Am J Physiol 1999, 277:G751-755.